CVS names John E. Gallina as reporting director

CVS Health Corp filed an initial ownership report for John E. Gallina, who is identified as a director of the company.

Accepted by SEC EDGAR 03/19/2026 - 05:26 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CVS Health Corp filed an initial ownership report for John E. Gallina, who is identified as a director of the company. This Form 3 does not list any stock transactions or holdings details in the provided data, serving mainly to register him as an insider for future reporting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CVS Form 3 filing for John E. Gallina show?

The Form 3 shows that John E. Gallina is a director of CVS Health Corp. It serves as his initial insider ownership report, and the provided data contains no listed stock transactions or detailed holdings information.

Does the CVS (CVS) Form 3 for John E. Gallina report any stock trades?

No, the Form 3 for CVS director John E. Gallina reports no stock transactions in the provided data. It functions only as an initial statement of insider status, without showing purchases, sales, or derivative exercises.

Why is CVS Health filing a Form 3 for John E. Gallina?

CVS Health filed a Form 3 because John E. Gallina is now a reporting insider as a director. SEC rules require insiders to file an initial ownership report when they become subject to ongoing reporting obligations for company securities.

What insider role does John E. Gallina have at CVS Health Corp (CVS)?

According to the Form 3, John E. Gallina is a director of CVS Health Corp. He is not listed as an officer or a ten percent owner in the provided data, so his insider status is based solely on board membership.

Does the CVS Form 3 indicate that John E. Gallina is a 10% owner?

The Form 3 states that John E. Gallina is not a ten percent owner of CVS Health Corp. His reporting status is tied to his role as a director rather than large share ownership, and no holdings amounts are disclosed in the provided data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gallina John E

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RHODE ISLAND 02895

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/19/2026

3. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ John E. Gallina	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)